Ketamine and Esketamine: Is There a Meaningful Clinical Difference?
Samuel T Wilkinson1,2, Taeho Greg Rhee1
1Yale Depression Research Program, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
No abstract available in PubMed .
More Related Videos
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
Related Concept Videos
Parenteral Anesthetics: Overview
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Electroconvulsive Therapy
Depolarizing Blockers: Pharmocokinetics
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
